Drug or Food. Interaction. Comments. Antacids (aluminum- and magnesium-containing) Possible increased blood tacrolimus concentrations 500. Monitor blood tacrolimus concentrations and adjust dosage as needed 500 CellCept official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. If insufficient peripheral blood mononuclear cells (PBMCs) are isolated from the patient's sample due to low WBC counts or specimen volume received, selected dilutions or stimulants may not be tested at the discretion of the laboratory to ensure the most reliable results. Mycophenolate Mofetil (CellCept) and Mycophenolate Sodium (Myfortic) are immunosuppressant drugs (a class of drugs that reduce the strength of the body’s immune system) used in the treatment of several autoimmune diseases. 5. Screening for head and neck emergencies or ares associated with non-extraglandular Sjögren’s. Patients with Sjögren’s whose disease is confined to the salivary glands, eye, head and neck areas occasionally develop complications, which may mandate emergent treatment. I take Cellcept for Myasthenia Gravis and i have been on it since 06 with no problems at all.It is very important to have your blood checked because it can effect your white blood count.When i first started i had bloodwork done every month for 3 months and now i have it done every 3 months. CellCept is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Mycophenolic acid, also called mycophenolate, is an immunosuppressant drug used to prevent rejection in organ transplantation. It was initially introduced as the prodrug mycophenolate mofetil (MMF, trade name CellCept) to improve oral bioavailability. Learn about CellCept (Mycophenolate Mofetil) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Immunosuppression may lead to increased susceptibility to infection. Bacterial, viral, protozoal, and fungal infection occur commonly during immunosuppressive therapy and can be fatal.